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Three forms of mercury exist: elemental, inorganic and organic, all 
of which may be toxic with clinical consequences, depending on the 
type of exposure. Elemental mercury poisoning usually occurs via 
vapour inhalation, as mercury is well absorbed through the lungs. 
The central nervous system is then the major site of deposition. 
Elemental mercury is the well-known silver liquid and usually causes 
pulmonary, neurological and nephrological toxicity.[1] Sources of 
exposure are mainly occupation related and include thermometer 
and barometer manufacturing, and gold mining, where liquefied 
elemental mercury may be used to concentrate gold. Other sources 
are dentistry, as amalgam dental fillings consist of mercury, and metal 
refineries.[1]
Inorganic mercury is present in an oxidised state, allowing the 
formation of mercury salts and, if ingested, may cause gastroenteritis 
and renal failure. The kidneys are the final site for deposition. 
Sources of inorganic mercury exposure may include occupational 
exposure in the electroplating industry and exposure to laboratory 
reagents.[1]
In this case report, intravenous complications, treatment strategies 
and possible neuropsychiatric manifestations, where there is pre-
existing mental disease, are explored in a South African (SA) setting. 
As far as the author is aware this is the first reported case in SA.
Case report
A 29-year-old man presented to Tambo Memorial Hospital, Boks burg, 
SA in June 2016 after having injected mercury intra venously his right 
and left arms 10 weeks earlier in an attempted suicide. The patient 
had presented owing to nonspecific symptoms of loss of appetite, 
occasional diarrhoea and fatigue. On further questioning a history of 
intravenous mercury injection was uncovered.
The patient was known to suffer from bipolar mood disorder type 1, 
diagnosed in 2010, with subsequent default of treatment in the same 
year, soon after initiating treatment. Three previous suicide attempts 
were reported. At this presentation, the patient was not expressing 
suicidal ideation or features of major depression.
Clinically the patient was stable, apyrexial and not distressed. 
Systemic examination was largely unremarkable, except for multiple 
areas of induration and granuloma formation on the right and left 
forearms.
Radiographs of the forearms, chest and abdomen were obtained 
(Figs 1 - 4). Images showed numerous metallic hyperdensities in the 
soft tissues surrounding the sites of intravenous injection (Figs 1 and 2) 
as well as numerous small hyperdensities throughout the lung fields 
(Fig. 3), abdomen and pelvis (Fig. 4).
Blood mercury level is indicative of short-term exposure and its 
measurement is not of great benefit in chronic exposure;[1]  therefore, 
this was not tested. Hair mercury levels are a good indication of 
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Fig. 1. Radiograph of the right forearm.
Fig. 2. Radiograph of the right elbow.
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chronic exposure leading to toxicity;[1] however, following discus-
sion with the National Institute for Occupational Health (NIOH), 
Johannesburg, SA, considering the cost and already significantly 
raised urinary levels, it was decided not to test hair levels.
The patient was admitted with an acute kidney injury for treatment 
with intravenous fluids and further investigation of the mercury 
injection and bipolar mood disorder.
On subsequent psychiatric evaluation of the patient, further 
information was obtained. The patient’s suicide attempt 3 months 
previously was precipitated by severe stressors at the time, including 
loss of employment, involvement in a motor vehicle accident with 
resultant loss of his car, and his father having suffered from a cerebral 
vascular accident. These events were subsequently followed by mood 
symptoms, resulting in the mercury injection. The patient was 
reportedly not experiencing mood or manic symptoms prior to these 
stressors, according to his mother, despite having defaulted treatment 
for bipolar mood disorder. He was not experiencing any psychotic or 
ictal symptoms at the time of admission. He did describe a history 
of panic attacks since the age of 20, during which he experiences 
sudden fear, palpitations, shortness of breath, shaking and light-
headedness, often associated with agoraphobia. Further stressors 
included an experience of date rape at the age of 22, shortly before the 
index episode with the first suicide attempt. Treatment with sodium 
valproate and lamotrigine was started at that stage. On mental state 
examination, he was noted to have a low mood with no features of 
major depression, mania or hypomania, and was not suicidal. The 
patient was restarted on lamotrigine.
Because of the appearance of multiple hyperdensities within the 
lung field on chest X-ray, the patient was discussed with staff at the 
respiratory unit at the referral hospital. No further treatment was 
advised at this point, but discussion with the nephrology department 
was suggested to assess further treatment options and the possibility of 
dialysis. Results of blood tests done on admission are shown in Table 1.
During admission, the patient’s creatinine level increased to 169 µmol/L, 
urea level was 13 mmol/L and electrolytes were normal. Urine 
testing gave a urine protein:creatinine ratio of 0.33 g/mmol (nor-
mal <0.015 g/mmol, nephrotic range >0.350 g/mmol; references from the 
NHLS, Johannesburg). After discussion with the nephrology depart-
ments of both Charlotte Maxeke Academic Hospital, Johannesburg, 
and Groote Schuur Hospital, Cape Town, it was decided that no ben-
efit would be derived from dialysis, but long-term chelation would 
most likely be necessary.
The case was further referred to the Department of Clinical 
Pharmacology at the University of Cape Town, which, in discussion 
with the Medicines Control Council (MCC), advised lifelong treat-
ment with penicillamine.
Documented consent was obtained from the patient for the writing 
of this case report and the publication of radiographs and blood 
analysis results.
Discussion
Organic mercury toxicity often leads to gastrointestinal, neurological 
and pulmonary symptoms, as organic mercury deposits in the kidneys 
and liver and in the central nervous system.[2]
Most documented clinical sequelae of mercury toxicity are from 
exposure to vaporised elemental mercury or ingestion of other forms 
of mercury.[1] Initial signs and symptoms may include cough, pleuritic 
chest pain, stomatitis, gingivitis, nausea, vomiting and diarrhoea, con-
junctivitis and dermatitis.
Prolonged exposure can lead to neurological and psychiatric symp-
toms, such as insomnia and tremors. A traditional pathognomonic 
feature of mercury toxicity is known as erethism mercurialis, consist-
ing mainly of neurological manifestations. Features include change in 
personality, anxiousness, irritability, insomnia, depression and drowsi-
ness.[1] However, the effect on the central nervous system in pre-existing 
Table 1. Initial blood analysis results of patient
Component Value
Reference 
range*
Urea (mmol/L) 11.5 2.1 - 7.1
Creatinine (µmol/L) 129 64 - 104
Total protein (g/L) 77 60 - 78
Albumin (g/L) 46 35 - 52
Alanine transaminase (µ/L) 7 10 - 40
Aspartate transaminase (µ/L) 18 15 - 40
C-reactive protein (mg/L) 35 <10
Thyroid-stimulating hormone (mU/L) 1.29 0.27 - 4.2
Haemoglobin (g/dL) 14.8 13.4 - 17.5
Urinary mercury (µg/mL) >150 000 2.5†
*References obtained from the National Health Laboratory Service (NHLS), Tambo
  Memorial Hospital.
†Reference obtained from NIOH.
Fig. 4. Radiograph of the abdomen and pelvis.
Fig. 3. Radiograph of the chest.
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mental illness remains to be seen. Rare cases of nephrotic syndrome 
have been described. Renal tubular dysfunction has also been noted.[1]
A diagnosis of mercury toxicity is confirmed in blood and 24-hour 
urine collection levels, but is dependent on whether the patient has 
had acute or prolonged exposure.
Treatment strategies include removing the source of exposure if 
possible, bronchodilators for respiratory complications, and careful fluid 
and electrolyte management for patients with gastrointestinal features.
Chelation therapy increases urinary excretion of mercury and has been 
shown to improve clinical manifestations.[3] Chelation is recommended 
by the World Health Organization for severe mercury toxicity.
Toxicity from intravenous injection of mercury usually occurs in 
relation to attempted suicide, accidental exposure, or possibly through 
experimentation by drug addicts.[4] Intravenous injection of mercury 
has been shown to be less detrimental than ingestion or inhalation. 
The heavy metal moves to dependent areas and extravasates into tis-
sues. It is then transported via the circulation, where it tends to lodge 
in the lungs and mediastinum and is also known to reach other organs 
over a period of time.[5]
Treatment strategies for intravenous injection are still being 
explored, but some show areas of promise. Chelation is of benefit; 
however, the effect of long-term chelation for chronic parenteral 
exposure is still uncertain.[6] The excision of deposits is also a sug-
gested strategy.[7]
Currently, penicillamine is a section 21 substance according to 
the Medicines and Related Substances Act 101 of 1965, regulated by 
the MCC. The hospital pharmacy involved in this case is trying to 
procure the drug.
Other treatment options include dialysis and surgical removal of 
granulomas and subcutaneous deposits, which have shown benefit.[7] 
In discussion with the patient it was ultimately decided to treat him 
medically at this stage and consider surgical intervention later.
Further psychiatric evaluation and monitoring was suggested 
based on the patient’s pre-existing mental state, and the possibility 
of neuropsychiatric manifestations of mercury toxicity as described 
above. Suggested further monitoring includes regular renal function 
testing, and dialysis could be considered depending on the burden 
of disease. A multidisciplinary approach involving dental and oph-
thalmology assessments to screen for the possible complications 
described above, as well as a surgical review to assess the possibility 
of deposit excision, may be recommended in similar cases.
The patient is waiting for penicillamine delivery via a section 21 
application and is attending the outpatient department at Tambo 
Memorial Hospital, where renal function monitoring continues and 
psychiatric progression of the disease is being monitored.
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